Zacks Investment Research has recently initiated coverage of Cumberland Pharmaceuticals Inc. (CPIX) with an “Outperform” recommendation, citing the company’s differentiated specialty pharmaceutical model, durable revenue opportunities and multiple long-term growth drivers.Cumberland Pharmaceuticals is a Nashville-based specialty pharma company focused on acquiring, developing and commercializing branded prescription products in hospital acute care, gastroenterology and oncology markets. The company’s strate ...